We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
dc.contributor.author | Ntwasa, Monde![]() |
|
dc.contributor.author | Dlamini, Zodwa![]() |
|
dc.date.accessioned | 2024-12-04T12:30:44Z | |
dc.date.available | 2024-12-04T12:30:44Z | |
dc.date.issued | 2024-04 | |
dc.description.abstract | No abstract available. | en_US |
dc.description.department | Medical Oncology | en_US |
dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
dc.description.sponsorship | The South African Medical Research Council (SAMRC), and the National Research Foundation (NRF). | en_US |
dc.description.uri | https://www.frontiersin.org/journals/genetics | en_US |
dc.identifier.citation | Ntwasa, M. & Dlamini, Z. (2024), Editorial: Molecular targets for anticancer drug discovery and development. Frontiers in Genetics 15:1374867. doi: 10.3389/fgene.2024.1374867. | en_US |
dc.identifier.issn | 1664-8021 (online) | |
dc.identifier.other | 10.3389/fgene.2024.1374867 | |
dc.identifier.uri | http://hdl.handle.net/2263/99767 | |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Media | en_US |
dc.rights | © 2024 Ntwasa and Dlamini. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY). | en_US |
dc.subject | Small molecule anticancer drugs | en_US |
dc.subject | Molecularly targeted therapies | en_US |
dc.subject | Pharmacogenetics | en_US |
dc.subject | Model organisms (Drosophila) | en_US |
dc.subject | Drug repurposing | en_US |
dc.subject | SDG-03: Good health and well-being | en_US |
dc.subject | Editorial | en_US |
dc.title | Editorial : Molecular targets for anticancer drug discovery and development | en_US |
dc.type | Article | en_US |